Fulcrum Therapeutics (FULC) EBITDA Margin (2018 - 2026)
Fulcrum Therapeutics' EBITDA Margin was -25.37% in FY2024, up 3841.44 percentage points from -3866.81% in FY2023.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) EBITDA Margin (2018 - 2026) Analysis & Trends
From FY2020 onward, Fulcrum Therapeutics has reported EBITDA Margin for 5 years.
- EBITDA Margin shows a four-year change of +759.07 percentage points (FY2020 to FY2024).
- The FY2024 figure marks the highest annual EBITDA Margin in data going back to FY2020.
- Per Business Quant data, EBITDA Margin in earlier years was -3866.81% in FY2023 (-2130.02 pp), -1736.79% in FY2022 (-1326.94 pp), -409.85% in FY2021 (+374.59 pp) and -784.44% in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Fulcrum Therapeutics | 282.94 Mn | -60.40 Mn | - | -929.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -929.73% |
| Mar 31, 2026 | -663.07% |
| Mar 31, 2025 | -727.91% |
| Jun 30, 2024 | 66.12% |
| Dec 31, 2023 | -3,156.37% |
| Sep 30, 2023 | -3,549.41% |
| Jun 30, 2023 | -3,033.18% |
| Mar 31, 2023 | -9,267.80% |
| Dec 31, 2022 | -3,997.37% |
| Sep 30, 2022 | -2,008.03% |
| Jun 30, 2022 | -1,781.88% |
| Mar 31, 2022 | -982.33% |
| Dec 31, 2021 | -453.62% |
| Sep 30, 2021 | -408.71% |
| Jun 30, 2021 | -433.28% |
| Mar 31, 2021 | -343.29% |
| Dec 31, 2020 | -403.15% |
| Sep 30, 2020 | -1,006.71% |
| Jun 30, 2020 | -766.20% |
| Mar 31, 2020 | -2,434.27% |
API Access
Fulcrum Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();